Dexta Corporation

Form 483 issued February 3, 2015 · Napa, California

Inspection
Jan 20 – Feb 3, 2015
Investigator
Jude C. Dike
Observations
7
Pages
4
FEI number
2916273

In short: On February 3, 2015, FDA issued a Form 483 with 7 observations to Dexta Corporation in Napa, California (FEI 2916273) after an inspection that ran Jan 20 – Feb 3, 2015. The investigator was Jude C. Dike. Most observations concern production & process controls and cAPA.

At a glance

Production & process controls and capa account for 5 of 7 observations.

Production & process controls4
CAPA1
Management controls1
Other1

What FDA observed

Preview: the opening words of each observation
  1. 01

    A process whose results cannot be fully verified by subsequent inspection and test has not been…

  2. 02

    Procedures to ensure that all purchased or otherwise received product and services conform to specified requirements…

  3. 03

    Procedures for acceptance activities have…

  4. 04

    Procedures for receiving, reviewing, and evaluating complaints by a formally designated unit…

3 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Dexta Corporation?

FDA listed 7 observations on this Form 483, mostly about production & process controls, cAPA and management controls. The opening words of each observation are shown on this page.

Who inspected Dexta Corporation?

Jude C. Dike is named on this Form 483, for the inspection of Jan 20 – Feb 3, 2015. Each investigator has a profile showing what they cite most.

When was Dexta Corporation inspected by FDA?

The inspection ran Jan 20 – Feb 3, 2015, and the Form 483 is dated February 3, 2015.

How do I get the full Form 483 for Dexta Corporation?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free